drugset / Trial / NCT03557424
BEFORE Study, Efficacy of Refigura
RandomizedParallel-groupTriple-blindTreatment
Summary
The BEFORE study ((B) EFficacy Of REfigura) is designed to demonstrate the efficacy of REFIGURA®. It is a double-blind, randomized, monocentric study.
Timeline
- Start
- 2017-04-26
- Primary completion
- 2018-04-16
- Completion
- 2018-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KONJAC MANNAN | Other / unclassified | 1 g | Oral |
| Subject | KONJAC MANNAN | Other / unclassified | 1.34 g | Oral |
| Subject | Polyglucosamine | Other / unclassified | 0.5 g | Oral |
| Subject | Polyglucosamine | Other / unclassified | 1 g | Oral |
Indications
No indication recorded.